Ucb And Ariceum Therapeutics Announced An Exclusive Strategic Research Collaboration Agreement To Identify And Develop Novel Systemic Targeted Radiopharmaceuticals For The Treatment Of Immune-Related Diseases And Solid Tumours.Under The Terms Of The Research Collaboration, Ucb And Ariceum Will Utilize Each Other
